ArticleInternal medicine (Tokyo, Japan)2021

Efficacy and Safety of Ramucirumab in Patients with Unresectable Hepatocellular Carcinoma with Progression after Treatment with Lenvatinib.

Kayoko Kasuya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.